Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $9.64 and last traded at $9.64, with a volume of 1001 shares traded. The stock had previously closed at $8.80.
Aspen Pharmacare Price Performance
The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.66 and a current ratio of 3.64. The company’s 50-day moving average is $9.09 and its two-hundred day moving average is $8.63.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Recommended Stories
- Five stocks we like better than Aspen Pharmacare
- Sezzle’s BNPL Growth Is Working, But the Stock Comes With a Catch
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
